Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bristol-Myers Squibb (NY: BMY ) 45.30 +0.60 (+1.34%) Streaming Delayed Price Updated: 12:54 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bristol-Myers Squibb < Previous 1 2 3 4 5 6 7 8 9 ... 40 41 Next > Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review Today 11:34 EDT Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. Via Investor's Business Daily Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points Today 2:59 EDT Via Benzinga Topics Stocks Exposures US Equities Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results April 25, 2024 Via Benzinga Exposures Fossil Fuels Why Bristol Myers Squibb Stock Is Sinking Today April 25, 2024 Investors didn't like the biopharmaceutical company's updated guidance. Via The Motley Fool A Closer Look at Bristol-Myers Squibb's Options Market Dynamics April 19, 2024 Via Benzinga Market Whales and Their Recent Bets on BMY Options April 15, 2024 Via Benzinga Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 25, 2024 Via Benzinga Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions April 25, 2024 Discover Bristol Myers Squibb's impressive first-quarter performance, with revenues exceeding expectations driven by key products like Eliquis and Reblozyl. Despite challenges, the company aims for... Via Benzinga PLTR Stock: Palantir Beefs Up Healthcare AI Work Through Parexel Deal April 25, 2024 Palantir stock is slipping on Thursday even as PLTR traders learn of a new contract between the data company and Parexel. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024 April 25, 2024 BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts April 25, 2024 Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024. Via InvestorPlace Topics Workforce Exposures Layoff Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript April 25, 2024 BMY earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial Is Bristol Myers Squibb Stock a Millionaire Maker? April 25, 2024 Bristol Myers Squibb faces some challenges, but there could be light at the end of the tunnel for long-term investors. Via The Motley Fool Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market April 25, 2024 The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate. Via Investor's Business Daily AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags April 25, 2024 AstraZeneca soundly topped analyst views while Sanofi narrowed its losses. Both stocks surged in early trade. Via Investor's Business Daily US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst April 25, 2024 The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META) Via Benzinga Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook April 23, 2024 Discover Novartis' Q1 EPS soars 17% to $1.80, surpassing estimates. Sales hit $11.83B, up 10%. Entresto sales surge 36%, Cosentyx up 25%. CEO Vas Narasimhan bullish on mid & long-term growth. Via Benzinga 5 Crash-Proof Stocks to Buy Immediately April 22, 2024 We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks. Via InvestorPlace 3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations April 20, 2024 These stocks pay between 3.2% and 6.7% in dividends. Via The Motley Fool These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? April 19, 2024 Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game. Via InvestorPlace FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies April 19, 2024 Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel Via Benzinga Exposures Product Safety Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week April 21, 2024 Corporate profit growth rose in Q3 2023 and is expected to continue in Q1. Via Benzinga Got $500? 3 Healthcare Stocks to Buy and Hold Forever April 19, 2024 Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk. Via The Motley Fool 3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500 April 17, 2024 If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential. Via InvestorPlace Topics Stocks Exposures US Equities 2 High-Yield Dividend Stocks to Buy and Hold for 10 Years April 17, 2024 These income stocks look like good options at current levels. Via The Motley Fool 3 Pharma Stocks That Are Money-Printing Machines in 2024 April 15, 2024 The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks. Via InvestorPlace Topics Economy Exposures Economy Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug April 15, 2024 The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect. Via Investor's Business Daily Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF? April 15, 2024 Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF? Via The Motley Fool Topics Stocks Exposures US Equities Better Growth Play: Merck or The Vanguard Growth Index Fund? April 15, 2024 Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund? Via The Motley Fool Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom April 12, 2024 The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 40 41 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.